[Postmenopausal osteoporosis].
Miki
Takami
T
Geriatric and Neurology, Osaka City University Medical Hospital.
Tamura
Akiko
A
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000172:deficiency; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004967:Estrogens; D020849:Raloxifene Hydrochloride